MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Total assets 2016–2024
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) total assets at each fiscal year-end, per SEC filings.
$25.1MFY2024 · since FY2016: $8.4M → $25.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $25.1M | -44.0% |
| FY2023 | $44.8M | -26.9% |
| FY2022 | $61.3M | -13.6% |
| FY2021 | $71.0M | +76.4% |
| FY2020 | $40.2M | +101.8% |
| FY2019 | $19.9M | +38.3% |
| FY2018 | $14.4M | +46.9% |
| FY2017 | $9.8M | +16.8% |
| FY2016 | $8.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MTNB financial trends
MTNB RevenueMTNB Net incomeMTNB Net marginMTNB Gross profitMTNB Gross marginMTNB Operating incomeMTNB Operating marginMTNB Operating cash flowMTNB Free cash flowMTNB Capital expendituresMTNB Return on equityMTNB Stock buybacksMTNB Dividends paidMTNB Total liabilitiesMTNB Shareholders’ equityMTNB overview →